Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
39
PEG Quote, Financials, Valuation and Earnings
Last price:
$82.76
Seasonality move
:
0.1%
Day range:
$81.24 - $82.41
52-week range:
$73.72 - $95.22
Dividend yield:
2.99%
P/E ratio:
22.45x
P/S ratio:
3.82x
P/B ratio:
2.50x
Volume:
2.5M
Avg. volume:
2.7M
1-year change:
10.24%
Market cap:
$41B
Revenue:
$10.3B
EPS (TTM):
$3.66
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $9.6B | $9.7B | $9.8B | $11.2B | $10.3B | |
| Revenue Growth (YoY) | -4.69% | 1.24% | 0.8% | 14.66% | -8.43% | |
| Cost of Revenues | $6.2B | $6.7B | $7.2B | $6.4B | $6.7B | |
| Gross Profit | $3.4B | $3B | $2.6B | $4.8B | $3.5B | |
| Gross Profit Margin | 35.74% | 30.83% | 26.57% | 42.96% | 34.41% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -$328M | -$376M | $218M | -- | |
| Other Inc / (Exp) | $636M | -$2.4B | -$5M | -$44M | $194M | |
| Operating Expenses | $1.3B | $1.2B | $1.1B | $1.1B | $1.2B | |
| Operating Income | $2.1B | $1.8B | $1.5B | $3.7B | $2.4B | |
| Net Interest Expenses | $446M | $421M | $470M | $567M | $728M | |
| EBT. Incl. Unusual Items | $2.3B | -$1.1B | $1B | $3.1B | $1.8B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $396M | -$441M | -$29M | $518M | $53M | |
| Net Income to Company | $1.9B | -$648M | $1B | $2.6B | $1.8B | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $1.9B | -$648M | $1B | $2.6B | $1.8B | |
| Basic EPS (Cont. Ops) | $3.78 | -$1.29 | $2.07 | $5.15 | $3.56 | |
| Diluted EPS (Cont. Ops) | $3.76 | -$1.29 | $2.06 | $5.13 | $3.54 | |
| Weighted Average Basic Share | $504M | $504M | $498M | $498M | $498M | |
| Weighted Average Diluted Share | $507M | $504M | $501M | $500M | $500M | |
| EBITDA | $4.3B | $814M | $2.8B | $5.1B | $4B | |
| EBIT | $2.8B | -$589M | $1.6B | $3.8B | $2.7B | |
| Revenue (Reported) | $9.6B | $9.7B | $9.8B | $11.2B | $10.3B | |
| Operating Income (Reported) | $2.1B | $1.8B | $1.5B | $3.7B | $2.4B | |
| Operating Income (Adjusted) | $2.8B | -$589M | $1.6B | $3.8B | $2.7B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $2.9B | $2.3B | $3.8B | $2.8B | $3.2B | |
| Revenue Growth (YoY) | 3.88% | -19.94% | 62.34% | -26.5% | 16.74% | |
| Cost of Revenues | $1.8B | $2B | $1.8B | $1.8B | $2.1B | |
| Gross Profit | $1.1B | $274M | $1.9B | $980M | $1.1B | |
| Gross Profit Margin | 37.45% | 11.85% | 51.4% | 35.51% | 34.67% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -$28M | -- | -- | |
| Other Inc / (Exp) | $170M | $2M | $62M | $123M | $33M | |
| Operating Expenses | $357M | $310M | $254M | $295M | $320M | |
| Operating Income | $725M | -$36M | $1.7B | $685M | $797M | |
| Net Interest Expenses | $130M | $120M | $153M | $179M | $213M | |
| EBT. Incl. Unusual Items | $765M | -$154M | $1.6B | $629M | $617M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $117M | -$152M | $298M | $97M | $28M | |
| Net Income to Company | $648M | -$2M | $1.3B | $532M | $589M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $648M | -$2M | $1.3B | $532M | $589M | |
| Basic EPS (Cont. Ops) | $1.29 | -$0.00 | $2.59 | $1.07 | $1.18 | |
| Diluted EPS (Cont. Ops) | $1.28 | -$0.00 | $2.58 | $1.06 | $1.18 | |
| Weighted Average Basic Share | $504M | $501M | $497M | $499M | $498M | |
| Weighted Average Diluted Share | $507M | $501M | $500M | $500M | $500M | |
| EBITDA | $1.3B | $316M | $2.1B | $1.2B | $1.2B | |
| EBIT | $911M | -$17M | $1.8B | $834M | $858M | |
| Revenue (Reported) | $2.9B | $2.3B | $3.8B | $2.8B | $3.2B | |
| Operating Income (Reported) | $725M | -$36M | $1.7B | $685M | $797M | |
| Operating Income (Adjusted) | $911M | -$17M | $1.8B | $834M | $858M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $9.7B | $9.1B | $11.2B | $10.2B | $10.8B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $6.3B | $7B | $7B | $6.4B | $7.1B | |
| Gross Profit | $3.4B | $2.2B | $4.3B | $3.9B | $3.7B | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | $920M | -$2.6B | $78M | -$41M | $86M | |
| Operating Expenses | $1.3B | $1.2B | $1.1B | $1.1B | $1.2B | |
| Operating Income | $2.1B | $1B | $3.2B | $2.8B | $2.5B | |
| Net Interest Expenses | $420M | $392M | $526M | $592M | $762M | |
| EBT. Incl. Unusual Items | $2.6B | -$2B | $2.7B | $2.1B | $1.8B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $469M | -$710M | $421M | $317M | -$16M | |
| Net Income to Company | $2.1B | -$1.3B | $2.3B | $1.8B | $1.8B | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $2.1B | -$1.3B | $2.3B | $1.8B | $1.8B | |
| Basic EPS (Cont. Ops) | $4.18 | -$2.57 | $4.66 | $3.64 | $3.66 | |
| Diluted EPS (Cont. Ops) | $4.16 | -$2.57 | $4.64 | $3.60 | $3.66 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | $4.5B | -$190M | $4.6B | $4.2B | $4.1B | |
| EBIT | $3.1B | -$1.5B | $3.3B | $2.8B | $2.7B | |
| Revenue (Reported) | $9.7B | $9.1B | $11.2B | $10.2B | $10.8B | |
| Operating Income (Reported) | $2.1B | $1B | $3.2B | $2.8B | $2.5B | |
| Operating Income (Adjusted) | $3.1B | -$1.5B | $3.3B | $2.8B | $2.7B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $2.9B | $2.3B | $3.8B | $2.8B | $3.2B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $1.8B | $2B | $1.8B | $1.8B | $2.1B | |
| Gross Profit | $1.1B | $274M | $1.9B | $980M | $1.1B | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -$28M | -- | -- | |
| Other Inc / (Exp) | $170M | $2M | $62M | $123M | $33M | |
| Operating Expenses | $357M | $310M | $254M | $295M | $320M | |
| Operating Income | $725M | -$36M | $1.7B | $685M | $797M | |
| Net Interest Expenses | $130M | $120M | $153M | $179M | $213M | |
| EBT. Incl. Unusual Items | $765M | -$154M | $1.6B | $629M | $617M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $117M | -$152M | $298M | $97M | $28M | |
| Net Income to Company | $648M | -$2M | $1.3B | $532M | $589M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $648M | -$2M | $1.3B | $532M | $589M | |
| Basic EPS (Cont. Ops) | $1.29 | -$0.00 | $2.59 | $1.07 | $1.18 | |
| Diluted EPS (Cont. Ops) | $1.28 | -$0.00 | $2.58 | $1.06 | $1.18 | |
| Weighted Average Basic Share | $504M | $501M | $497M | $499M | $498M | |
| Weighted Average Diluted Share | $507M | $501M | $500M | $500M | $500M | |
| EBITDA | $1.3B | $316M | $2.1B | $1.2B | $1.2B | |
| EBIT | $911M | -$17M | $1.8B | $834M | $858M | |
| Revenue (Reported) | $2.9B | $2.3B | $3.8B | $2.8B | $3.2B | |
| Operating Income (Reported) | $725M | -$36M | $1.7B | $685M | $797M | |
| Operating Income (Adjusted) | $911M | -$17M | $1.8B | $834M | $858M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $543M | $818M | $465M | $54M | $125M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $1.4B | $1.9B | $1.9B | $1.5B | $1.6B | |
| Inventory | $878M | $744M | $960M | $1B | -- | |
| Prepaid Expenses | $51M | $63M | $93M | $144M | $117M | |
| Other Current Assets | $396M | $408M | $402M | $3.1B | $4.1B | |
| Total Current Assets | $3.6B | $6.3B | $4.3B | $3.4B | $4.2B | |
| Property Plant And Equipment | $37.8B | $34.6B | $36.1B | $1.5B | $1.3B | |
| Long-Term Investments | $3.3B | $3.4B | $3B | $3B | -- | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | $158M | $20M | -- | -- | -- | |
| Other Long-Term Assets | $286M | $234M | $285M | $42.2B | $44.2B | |
| Total Assets | $50.1B | $49B | $48.7B | $50.7B | $54.6B | |
| Accounts Payable | $1.3B | $1.3B | $1.3B | $1.2B | $1.1B | |
| Accrued Expenses | $126M | $121M | $134M | $170M | $219M | |
| Current Portion Of Long-Term Debt | $1.7B | $700M | $1.6B | $1.5B | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | $1.2B | $1.4B | $1.5B | $5.1B | $6.5B | |
| Total Current Liabilities | $5.5B | $7.1B | $6.7B | $5.1B | $6.5B | |
| Long-Term Debt | $14.5B | $15.2B | $16.5B | $17.8B | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $34.1B | $34.6B | $35B | $35.3B | $38.5B | |
| Common Stock | $5B | $5B | $5.1B | $5B | -- | |
| Other Common Equity Adj | -$504M | -$350M | -$550M | -$179M | -- | |
| Common Equity | $16B | $14.4B | $13.7B | $13.4B | $14B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $16B | $14.4B | $13.7B | $15.5B | $16.1B | |
| Total Liabilities and Equity | $50.1B | $49B | $48.7B | $50.7B | $54.6B | |
| Cash and Short Terms | $543M | $818M | $465M | $54M | $125M | |
| Total Debt | $17.2B | $19.4B | $20.3B | $949M | $1.6B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $803M | $1.6B | $1.2B | $1.2B | $894M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $1.5B | $1.7B | $1.7B | $1.5B | $1.8B | |
| Inventory | $738M | $538M | $715M | $921M | $991M | |
| Prepaid Expenses | $76M | $100M | $101M | $119M | $104M | |
| Other Current Assets | $279M | $409M | $326M | $240M | $442M | |
| Total Current Assets | $3.6B | $4.7B | $4.3B | $4.3B | $4.8B | |
| Property Plant And Equipment | $38B | $34.9B | $36.5B | $38.7B | $40.4B | |
| Long-Term Investments | $3.3B | $3.2B | $3.1B | $3.1B | $3.1B | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | $163M | $22M | -- | -- | -- | |
| Other Long-Term Assets | $288M | $251M | $284M | $352M | $366M | |
| Total Assets | $50.2B | $47.8B | $49.4B | $52.4B | $55.6B | |
| Accounts Payable | $984M | $956M | $958M | $980M | $1.1B | |
| Accrued Expenses | $173M | $144M | $161M | $193M | $230M | |
| Current Portion Of Long-Term Debt | $1.4B | $700M | $1.8B | $2.5B | $2.6B | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | $1.1B | $1.5B | $1.2B | $1.2B | $1.5B | |
| Total Current Liabilities | $4.5B | $5.3B | $5.4B | $5.4B | $5.8B | |
| Long-Term Debt | $15.3B | $17B | $17.1B | $18.8B | $20.4B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $33.9B | $34.2B | $34.7B | $36.7B | $39.2B | |
| Common Stock | $5B | $5B | $5B | $5B | $5B | |
| Other Common Equity Adj | -$542M | -$410M | -$522M | -$169M | -$136M | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $16.3B | $13.6B | $14.7B | $15.7B | $16.4B | |
| Total Liabilities and Equity | $50.2B | $47.8B | $49.4B | $52.4B | $55.6B | |
| Cash and Short Terms | $803M | $1.6B | $1.2B | $1.2B | $894M | |
| Total Debt | $17.4B | $19.3B | $20.2B | $21.8B | $23.4B | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $1.9B | -$648M | $1B | $2.6B | $1.8B | |
| Depreciation & Amoritzation | $1.5B | $1.4B | $1.3B | $1.3B | $1.4B | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | $107M | -- | $1M | $75M | -$384M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $3.1B | $1.7B | $1.5B | $3.8B | $2.1B | |
| Capital Expenditures | $3B | $2.7B | $2.9B | $3.3B | $3.4B | |
| Cash Acquisitions | -- | -$111M | -$124M | $291M | -- | |
| Cash From Investing | -$2.7B | -$2.2B | -$1.1B | -$3B | -$3.3B | |
| Dividends Paid (Ex Special Dividend) | -$991M | -$1B | -$1.1B | -$1.1B | -$1.2B | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $3.3B | $5.6B | $4.9B | $3.8B | $4.5B | |
| Long-Term Debt Repaid | -$2.2B | -$3.4B | -$4B | -$3.8B | -$2B | |
| Repurchase of Common Stock | -- | -- | -$500M | -- | -- | |
| Other Financing Activities | -$72M | -$369M | -$6M | -$98M | -$70M | |
| Cash From Financing | -$30M | $799M | -$754M | -$1.3B | $1.2B | |
| Beginning Cash (CF) | $176M | $572M | $863M | $511M | $99M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $396M | $291M | -$352M | -$412M | $55M | |
| Ending Cash (CF) | $572M | $863M | $511M | $99M | $154M | |
| Levered Free Cash Flow | $68M | -$983M | -$1.4B | $481M | -$1.2B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $648M | -$2M | $1.3B | $532M | $589M | |
| Depreciation & Amoritzation | $390M | $333M | $330M | $346M | $373M | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | $66M | $1M | $70M | $5M | $78M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $1B | $472M | $1.8B | $661M | $1B | |
| Capital Expenditures | $633M | $686M | $739M | $797M | $628M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$624M | $1.2B | -$714M | -$785M | -$618M | |
| Dividends Paid (Ex Special Dividend) | -$258M | -$271M | -$284M | -$299M | -$314M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $1.4B | $1.8B | $900M | $2.3B | $1.9B | |
| Long-Term Debt Repaid | -$1.2B | -$1.8B | -$950M | -$250M | -- | |
| Repurchase of Common Stock | -- | -$500M | -- | -- | -- | |
| Other Financing Activities | -$78M | -$12M | -$46M | -$27M | -$48M | |
| Cash From Financing | -$134M | -$876M | -$380M | $1.2B | $345M | |
| Beginning Cash (CF) | $572M | $863M | $511M | $99M | $154M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $269M | $779M | $743M | $1.1B | $776M | |
| Ending Cash (CF) | $841M | $1.6B | $1.3B | $1.2B | $930M | |
| Levered Free Cash Flow | $394M | -$214M | $1.1B | -$136M | $421M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $2.1B | -$1.3B | $2.3B | $1.8B | $1.8B | |
| Depreciation & Amoritzation | $1.5B | $1.3B | $1.3B | $1.3B | $1.4B | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | $157M | -$65M | $70M | $10M | -$311M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $3B | $1.2B | $2.9B | $2.6B | $2.5B | |
| Capital Expenditures | $2.9B | $2.8B | $2.9B | $3.4B | $3.2B | |
| Cash Acquisitions | -- | -- | -$124M | $291M | -- | |
| Cash From Investing | -$2.6B | -$437M | -$3B | -$3B | -$3.1B | |
| Dividends Paid (Ex Special Dividend) | -$1B | -$1B | -$1.1B | -$1.2B | -$1.2B | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $3.8B | $5.9B | $4B | $5.2B | $4.1B | |
| Long-Term Debt Repaid | -$3.1B | -$4B | -$3.1B | -$3.1B | -$1.8B | |
| Repurchase of Common Stock | -- | -$500M | -- | -- | -- | |
| Other Financing Activities | -$88M | -$303M | -$40M | -$79M | -$91M | |
| Cash From Financing | -$401M | $57M | -$258M | $369M | $324M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$1M | $801M | -$388M | -$30M | -$294M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $58M | -$1.6B | -$73M | -$753M | -$690M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $648M | -$2M | $1.3B | $532M | $589M | |
| Depreciation & Amoritzation | $390M | $333M | $330M | $346M | $373M | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | $66M | $1M | $70M | $5M | $78M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $1B | $472M | $1.8B | $661M | $1B | |
| Capital Expenditures | $633M | $686M | $739M | $797M | $628M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$624M | $1.2B | -$714M | -$785M | -$618M | |
| Dividends Paid (Ex Special Dividend) | -$258M | -$271M | -$284M | -$299M | -$314M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $1.4B | $1.8B | $900M | $2.3B | $1.9B | |
| Long-Term Debt Repaid | -$1.2B | -$1.8B | -$950M | -$250M | -- | |
| Repurchase of Common Stock | -- | -$500M | -- | -- | -- | |
| Other Financing Activities | -$78M | -$12M | -$46M | -$27M | -$48M | |
| Cash From Financing | -$134M | -$876M | -$380M | $1.2B | $345M | |
| Beginning Cash (CF) | $572M | $863M | $511M | $99M | $154M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $269M | $779M | $743M | $1.1B | $776M | |
| Ending Cash (CF) | $841M | $1.6B | $1.3B | $1.2B | $930M | |
| Levered Free Cash Flow | $394M | -$214M | $1.1B | -$136M | $421M | |
Get PEG Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
PEG
Sector
P/E ratio
22.45x
14.77x
PEG ratio
13.94x
0.35x
P/B ratio
2.50x
1.44x
Price / LTM sales
3.82x
1.58x
Growth Metrics
PEG
Sector
Revenue growth
16.74%
2.79%
Earnings growth
11.32%
-0.57%
Revenue (5-year growth)
0.42%
4.48%
Earnings forecast
$0.71
$0.39
Profitability
PEG
Sector
Profitability FY 2024
$3.5B
$1.3B
Return on invested capital
5.44%
3.5%
Return on assets
3.4%
2.53%
Return on equity
11.41%
8.06%
Earnings Date
Last Earnings Date
Apr
30
Next Earnings Date
Aug
5
Estimated Next Earnings Date
Jul
30
Balance Sheet
PEG
Sector
Total cash
$894M
$406.3M
Short term investments
--
$97.6M
Total assets
$54.6B
$11.2B
Long term debt
$23.4B
$3.2B
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
